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ABSTRACT
Background: Achalasia is a relatively rare disorder with
a variety of treatment options. Although laparoscopic
Heller myotomy has become the surgical treatment of
choice, little data exist on the overall quality of life of
patients undergoing this technique versus standard open
approaches. 
Methods: We prospectively evaluated all patients surgi-
cally treated for achalasia by a single surgeon.
Laparoscopic Heller myotomy consisted of a long (≥ 6
cm) esophageal cardiomyotomy extending at least 2 cm
onto the gastric cardia, with a concomitant Dor fundo-
plication. Patients were evaluated preoperatively and
postoperatively for symptoms and quality of life using
the SF-36, a standardized, generic quality of life instru-
ment. 
Results: A total of 23 patients were surgically treated: 15
patients had a planned laparoscopic procedure, with 3
conversions; 8 had planned open procedures. Dysphagia
resolved in 20 of 21 patients, with 1 patient in the laparo-
scopic group requiring reoperation due to an inadequate
gastric myotomy. Compared with preoperative scores, a
statistically significant improvement occurred in the gen-
eral health domain of the SF-36 (70 to 82, P = 0.04).
Compared with that in patients undergoing open surgery,
the laparoscopic group had better scores in the domains
of physical functioning and bodily pain. 
Conclusions: Laparoscopic Heller myotomy has compa-
rable success to open Heller myotomy, and causes less
early detriment to quality of life. This should be the pri-
mary treatment in all fit surgical patients with achalasia.
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INTRODUCTION
Achalasia is an uncommon, benign disorder of the
esophagus with an annual incidence of 1 per 100,000
people.1 It is characterized by a hypertensive, nonrelax-
ing lower esophageal sphincter (LES) associated with a
hypo- or aperistaltic esophageal body. The etiology of
this condition is unclear, but reason exists to believe that
it may be secondary to abnormal innervation of the
myenteric plexus of the esophagus.2 A recent study of 42
resected esophageal specimens from patients with acha-
lasia revealed fewer ganglion cells, and ganglion cells,
when present, surrounded by mononuclear cells, sug-
gesting a cause of ganglion degeneration.3
Hypotheses for acquired causes include viral infections
like herpes zoster4 or measles,5 or an autoimmune path-
ogenesis based on a description of antimyenteric neuron
antibodies.6 
Regardless of the cause of achalasia, its presentation is
quite characteristic. Patients usually present with dyspha-
gia, chest pain, regurgitation, weight loss, and occasion-
ally heartburn. In fact, achalasia can be misdiagnosed as
gastroesophageal reflux disease. The dysphagia is pro-
gressive and is associated with worsening esophageal
dilation. The diagnosis is confirmed with an esopha-
gogram, esophagoscopy, and esophageal manometry. 
Management of achalasia is directed at alleviation of symp-
toms, because currently no therapy exists for the underly-
ing neuropathology. Symptomatic improvement with med-
ical management is poor.2 The mainstays of treatment are
pneumatic dilation,2,6 endoscopic botulinum toxin injec-
tions,2,7 and surgical myotomy of the gastroesophageal
junction–the so-called Heller myotomy.2,8 Surgical inter-
vention was traditionally performed through a left thora-
cotomy. However, with the popularization of laparoscopy,
especially in relation to antireflux procedures, this
approach has gained popularity. Nevertheless, although a
plethora of studies report symptomatic outcomes of lap-
aroscopic or thoracoscopic Heller myotomies,2,8 none has
used a validated quality of life instrument to assessment
outcomes. We report here our experience with both open
and laparoscopic Heller myotomy, with prospectively
gathered quality of life outcomes.
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PATIENTS AND METHODS
All patients surgically treated for achalasia by a single sur-
geon (VV) at Henry Ford Hospital over the period of
September 1996 to December 2000 were eligible for the
study. Achalasia was documented preoperatively in all
patients by symptoms, upper gastrointestinal series,
upper endoscopy, and esophageal manometry. All treat-
ments prior to surgical intervention were recorded.
Preoperatively, patients completed the SF-36, a generic
quality of life instrument.8-11 This instrument has been
used in a variety of surgical outcome studies12-14 and was
therefore considered appropriate for this study. The SF-
36 measures 8 “domains” of quality of life: physical func-
tioning (PF), role-physical (RP), role-emotional (RE), bod-
ily pain (BP), vitality (VT), social functioning (SF), men-
tal health (MH), and general health (GH). All scores are
standardized so that the worst possible score is 0, and the
best possible score is 100 is each domain. The SF-36 does
not measure a “grand total” quality of life score. At 6
weeks postoperation, patients once again completed this
instrument.
The selection criteria for offering patients a laparoscopic
versus open Heller myotomy were as follows: patients
with an associated epiphrenic diverticulum, patients with
a previously failed Heller myotomy, patients with associ-
ated intraabdominal pathology requiring surgical inter-
vention not amenable to a laparoscopic approach, or
patients in whom a laparoscopic approach did not seem
feasible. All other patients, including those who under-
went prior pneumatic dilation or botulism toxin injec-
tions, were offered a laparoscopic Heller myotomy. 
Laparoscopic Heller myotomy was performed through 5
ports placed in a “diamond” fashion as described by
Hunter et al.15 The phrenicoesophageal ligament was
divided to expose the gastroesophageal junction; howev-
er, dissection in this area was kept to a minimum. The
esophageal fat pad was excised. The myotomy was
begun on the esophagus with a hook cautery until the
submucosal plane was identified. Care was taken to
divide both the longitudinal and circular fibers of the
esophageal musculature. The myotomy was extended at
least 6 cm along the esophagus and 2 cm onto the gas-
tric cardia. The length of the myotomy was controled by
intraoperative esophagogastroscopy to ensure complete-
ness of the myotomy. The operation was completed with
an anterior 180 degree Dor fundoplication.
The open Heller myotomy was performed through an
upper, midline incision. The details of the operation after
this were the same as those for the laparoscopic
approach, except for 3 patients who had transthoracic
Heller myotomies. These 3 patients did not receive a
concomitant antireflux procedure. All patients were stud-
ied with water-soluble or barium esophagogram, or both
of these, postoperatively to rule out occult leaks and doc-
ument resolution of the “bird’s beak.”
Statistical analysis was done with the True Epistat16 sta-
tistical computer program. As the data did not follow a
Gaussian distribution, they were analyzed nonparametri-
cally using the Mann-Whitney U test. A P-value of 0.05
was considered significant.
RESULTS
A total of 23 patients were surgically treated for achala-
sia during this period. Eight patients had previous treat-
ment with pneumatic dilation, and 3 were treated with
endoscopic injection of botulinum toxin. Fifteen patients
had laparoscopic Heller myotomy with Dor fundoplica-
tion, 3 of which required conversion to an open proce-
dure. Eight patients underwent a planned open proce-
dure: 2 were re-do myotomies, 3 patients due to associ-
ated epiphrenic diverticula, 2 due to obesity, and 1
patient with a concomitant abdominal mass. Three
esophageal perforations were recognized intraoperative-
ly, and 1 was repaired laparoscopically. Two of these 3
patients had prior botulinum toxin injections. Two con-
versions were because of perforations that could not be
repaired laparoscopically, and the other was due to an
inability to complete an adequate myotomy laparoscopi-
cally. 
Median length of stay was 2 days in the laparoscopic
group, compared with 6 days in the open group (P <
0.05). All patients reported dramatic improvement in
their symptoms in the immediate postoperative period.
Six weeks later, all but 1 patient in the laparoscopic
group still had excellent outcomes. The 1 patient had
persistent dysphagia and an esophageal stenosis by a
contrast esophagogram consistent with achalasia, which
was refractory to repeated pneumatic dilation. At reex-
ploration, it was discovered that the myotomy onto the
gastric cardia was incomplete. After extending the
myotomy and adding a Dor fundoplication, this patient
had complete symptomatic relief.Two patients in the transthoracic group eventually devel-
oped reflux requiring re-operation and a Dor fundopli-
cation. Another patient in this group developed a stric-
ture that responded to pneumatic balloon dilation. 
In addition to patients’ verbal assessments of their symp-
toms, each patient at 6 weeks follow-up completed the
SF-36. Figure 1 presents the median scores. Compared
with the open group, the laparoscopic group had better
scores in the domains of physical functioning (PF), role-
physical (RP), and vitality (VT) [P ≤ 0.05 for all compar-
isons]. Compared with preoperative scores, both the
laparoscopic and open groups showed improvement in
the general health (GH) domain [P = 0.04].
DISCUSSION
Like laparoscopic antireflux procedures, laparoscopic
Heller myotomy has gained popularity as the surgical
procedure of choice for achalasia. In fact, many gas-
troenterologists refer fit patients for surgery without pre-
vious attempts at pneumatic dilation or botulinum toxin
injection.2 Some have been influenced by the only ran-
domized trial comparing open Heller myotomy with
pneumatic dilation, which strongly favored surgical ther-
apy.17 In addition, the perception exists that the laparo-
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scopic approach is “less invasive” than either a laparoto-
my or thoracotomy for completion of the myotomy.
Nevertheless, quantitative data using well-validated qual-
ity of life instruments has been lacking to support this
assertion. We have shown here that the laparoscopic
approach offers similar symptomatic outcomes to that of
the open Heller myotomy, but with superior quality of
life outcomes in 3 of 8 measured domains. Although this
is not a randomized trial and is potentially open to bias,
these results are consistent with previously published
data comparing quality of life outcomes of open and
laparoscopic antireflux procedures.18
Nevertheless, some unsettled questions still exist with
respect to laparoscopic Heller myotomy. Firstly, can
laparoscopic Heller myotomy be done after pneumatic
dilation? We performed 7 myotomies after pneumatic
dilation without difficulty. Cosentini et al19 have also
shown that the laparoscopic approach is feasible and
effective after pneumatic dilation. Therefore, a previous
pneumatic dilation should not deter a surgeon from
choosing the laparoscopic approach.
Secondly, can laparoscopic Heller myotomy be done
after botulinum toxin injection? Botulinum toxin injection
results in fibrosis and obliteration of the submucosal
Figure 1. Median preoperative and postoperative SF-36 scores for patients undergoing laparoscopic and open Heller
myotomy with Dor fundoplication. PF = Physical functioning; RP = Role physical; RE = Role-emotional; BP = bodily
pain; VT = vitality; MH = mental health; SF = social functioning; GH = general health. * denotes statistically significant
differences between the laparoscopic and open groups (P ≤ 0.05). ** denotes statistically significant difference between
preoperative and postoperative scores (P < 0.05). Heller Myotomy for Achalasia: Quality of Life Comparison of Laparoscopic and Open Approaches, Katilius M et al.
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plane between the esophageal mucosa and muscula-
ture.20 This results in a much more difficult dissection and
a higher incidence of perforation, as demonstrated by the
fact that 2 of our 3 intraoperative perforations occurred in
patients receiving these injections. Therefore, as recom-
mended by some gastroenterologists,2,21 botulinum toxin
should be reserved for elderly patients who are not sur-
gical candidates. If a patient has already been treated
with this method, the surgeon can anticipate a difficult
dissection with a high likelihood of mucosal perforation.
Thirdly, is laparoscopic Heller myotomy effective for
patients with dilated, aperistaltic esophagi? Some have
suggested that marked dilated esophagi associated with
“sigmoid” changes as demonstrated by a contrast esoph-
agogram is an indication for esophagectomy with gastric
or colon interposition.22,23 Patti et al24 reported on a
group of such patients who have done well after laparo-
scopic Heller myotomy. Therefore, it would seem rea-
sonable that these patients can be offered a laparoscopic
myotomy first; then if this fails, an esophagectomy can be
the definitive procedure. 
Lastly, should a fundoplication be added to a Heller
myotomy? Traditionally, a partial fundoplication has been
added to the open, transabdominal Heller myotomy.8,25
However, this doctrine has been challenged by some sur-
geons performing the operation laparoscopically, claim-
ing that this approach causes minimal disruption at the
esophageal hiatus and therefore is less prone to
reflux.26,27 Shiino et al8 in a careful review of the litera-
ture, nevertheless, conclude that patients undergoing
open or laparoscopic Heller myotomy require a fundo-
plication, whereas, those treated thoracoscopically may
not. It has been our experience that patients who do not
undergo a concomitant fundoplication do suffer from
reflux symptoms; therefore, it is our policy to perform a
fundoplication on all patients.
In conclusion, laparoscopic Heller myotomy produces
similar symptomatic results as those of the open
approach with better quality of life outcomes. Patients
who are fit for surgery should be offered this as the pri-
mary and definitive treatment for achalasia. A partial,
anterior fundoplication (Dor) should be strongly consid-
ered, if not routine, for all patients undergoing a Heller
myotomy. 
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